AbbVie Inc.'s ticker is and the CUSIP is 002874Y10. A total of 2 filers reported holding AbbVie Inc. in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,015,000 | -12.6% | 25,000 | 0.0% | 0.37% | -24.3% |
Q4 2018 | $2,305,000 | -2.5% | 25,000 | 0.0% | 0.49% | +3.6% |
Q3 2018 | $2,364,000 | +2.1% | 25,000 | 0.0% | 0.48% | -4.6% |
Q2 2018 | $2,316,000 | -2.1% | 25,000 | 0.0% | 0.50% | -5.7% |
Q1 2018 | $2,366,000 | -2.2% | 25,000 | 0.0% | 0.53% | +1.7% |
Q4 2017 | $2,418,000 | +8.9% | 25,000 | 0.0% | 0.52% | -6.8% |
Q3 2017 | $2,221,000 | +22.5% | 25,000 | 0.0% | 0.56% | +14.3% |
Q2 2017 | $1,813,000 | +11.3% | 25,000 | 0.0% | 0.49% | -1.0% |
Q1 2017 | $1,629,000 | +4.1% | 25,000 | 0.0% | 0.49% | -7.5% |
Q4 2016 | $1,565,000 | -0.8% | 25,000 | 0.0% | 0.53% | +7.0% |
Q3 2016 | $1,577,000 | +1.9% | 25,000 | 0.0% | 0.50% | -1.4% |
Q2 2016 | $1,548,000 | +8.4% | 25,000 | 0.0% | 0.50% | +8.6% |
Q1 2016 | $1,428,000 | -3.6% | 25,000 | 0.0% | 0.46% | +0.4% |
Q4 2015 | $1,481,000 | +8.9% | 25,000 | 0.0% | 0.46% | +3.1% |
Q3 2015 | $1,360,000 | -19.0% | 25,000 | 0.0% | 0.45% | -16.1% |
Q2 2015 | $1,680,000 | +14.8% | 25,000 | 0.0% | 0.54% | -4.3% |
Q1 2015 | $1,463,000 | -10.6% | 25,000 | 0.0% | 0.56% | -3.1% |
Q4 2014 | $1,636,000 | +13.3% | 25,000 | 0.0% | 0.58% | +14.7% |
Q3 2014 | $1,444,000 | +2.3% | 25,000 | 0.0% | 0.50% | +10.5% |
Q2 2014 | $1,411,000 | +9.8% | 25,000 | 0.0% | 0.46% | -9.9% |
Q1 2014 | $1,285,000 | -2.7% | 25,000 | 0.0% | 0.50% | +9.5% |
Q4 2013 | $1,320,000 | +18.1% | 25,000 | 0.0% | 0.46% | +24.9% |
Q3 2013 | $1,118,000 | +8.2% | 25,000 | 0.0% | 0.37% | -11.3% |
Q2 2013 | $1,033,000 | – | 25,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLYNN CAPITAL MANAGEMENT LLC | 25,000 | $1,033,000 | 0.42% |
Cohen Capital Management, Inc. | 10,038 | $415,000 | 0.13% |